Cobra Venom Factor Boosts Arteriogenesis in Mice.

Area of Science:

• Vascular biology
• Immunology
• Regenerative medicine

Background:

• Arteriogenesis is crucial for compensating arterial loss in vascular occlusive diseases.
• Promoting innate immune-driven arteriogenesis is a therapeutic goal.
• Cobra venom factor (CVF) modulates the complement system.

Purpose of the Study:

• To investigate the effect of CVF on arteriogenesis in a murine hind limb model.
• To determine if CVF administration promotes collateral vessel growth and tissue perfusion recovery.

Main Methods:

• Murine hind limb model of arteriogenesis induced by femoral artery ligation (FAL).
• Single-dose CVF administration prior to FAL.
• Laser Doppler imaging for perfusion assessment.
• Immunofluorescence, flow cytometry, and Giemsa staining for cellular and molecular analysis.

Main Results:

• CVF administration significantly enhanced perfusion recovery 7 days post-FAL.
• Increased proliferation of vascular cells and augmented diameter of collateral vessels were observed.
• CVF promoted neutrophil, platelet-neutrophil aggregates, and mast cell recruitment and activation.
• Enhanced M2-like macrophage polarization around growing collaterals was noted.

Conclusions:

• A single dose of CVF effectively promotes arteriogenesis.
• CVF-induced enhancement of arteriogenesis is mediated by catalyzing innate immune reactions.
• These findings highlight CVF's potential therapeutic role in vascular occlusive diseases.